These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6505596)

  • 1. [How to evaluate the activity of Paget's disease in clinical practice and which patients should be treated?].
    Reiner JC; Bontoux-Carre E; Seret P; Villayleck S
    Rev Rhum Mal Osteoartic; 1984 Oct; 51(9):463-8. PubMed ID: 6505596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of Paget's disease of bone].
    Ziegler R; Frank K
    Dtsch Med Wochenschr; 1988 Jan; 113(3):100-2. PubMed ID: 3338383
    [No Abstract]   [Full Text] [Related]  

  • 3. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal distribution and biochemical parameters of Paget's disease.
    Meunier PJ; Salson C; Mathieu L; Chapuy MC; Delmas P; Alexandre C; Charhon S
    Clin Orthop Relat Res; 1987 Apr; (217):37-44. PubMed ID: 3103964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between signs and symptoms in Paget's disease of bone.
    Harinck HI; Bijvoet OL; Vellenga CJ; Blanksma HJ; Frijlink WB
    Q J Med; 1986 Feb; 58(226):133-51. PubMed ID: 3714967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Skeletal distribution and biological markers of Paget's disease].
    Meunier PJ; Salson C; Delmas PD
    Rev Prat; 1989 Apr; 39(13):1125-8. PubMed ID: 2786643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease.
    Walton RJ; Preston CJ; Russell RG; Kanis JA
    Clin Chim Acta; 1975 Sep; 63(2):227-9. PubMed ID: 1175295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactosyl hydroxylysine in assessment of Paget's bone disease.
    Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
    Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F; Alvarez L; Peris P; Guañabens N; Vidal-Sicart S; Monegal A; Pavía J; Ballesta AM; Muños-Gómez J; Herranz R
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paget's disease of the bones: diagnosis and treatment].
    Jacobs JW; Huisman AM; van Paassen HC; Bijlsma JW
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):719-25. PubMed ID: 10347626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone scintigraphy in osteodystrophia deformans (Paget's disease)].
    Jesserer H; Zita G; Drexler H
    Fortschr Med; 1977 Nov; 95(41):2451-8. PubMed ID: 914201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid function in Paget's disease of bone.
    Siris ES; Clemens TP; McMahon D; Gordon A; Jacobs TP; Canfield RE
    J Bone Miner Res; 1989 Feb; 4(1):75-9. PubMed ID: 2718781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paget's disease of bone (osteitis deformans): symptomatic lesions and bone scan.
    Khairi MR; Wellman HN; Robb JA; Johnston CC
    Ann Intern Med; 1973 Sep; 79(3):348-51. PubMed ID: 4748251
    [No Abstract]   [Full Text] [Related]  

  • 16. Scintigraphic aspects of the recurrence of treated Paget's disease of bone.
    Vellenga CJ; Pauwels EK; Bijvoet OL; Frijlink WB
    J Nucl Med; 1981 Jun; 22(6):510-7. PubMed ID: 7229723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoma arising in Paget's disease of bone: declining incidence and increasing age at presentation.
    Mangham DC; Davie MW; Grimer RJ
    Bone; 2009 Mar; 44(3):431-6. PubMed ID: 19064007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
    Ryan PJ; Gibson T; Fogelman I
    J Nucl Med; 1992 Sep; 33(9):1589-93. PubMed ID: 1517830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone alkaline phosphatase in Paget's disease.
    Deftos LJ; Wolfert RL; Hill CS
    Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.